BPR-6023021
N/A
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameBPR-6023021
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChengdu Xinke Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesBeijing Quarkxia Technology Co LtdChengdu Xinke Medicine Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A